| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | Mikhail Nikiforov | |
| P2860 | cites work | BMAL1-dependent regulation of the mTOR signaling pathway delays aging | Q28592920 |
| Rapamycin-induced metabolic defects are reversible in both lean and obese mice | Q34461128 | ||
| Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to | Q36062176 | ||
| Rejuvenating immunity: "anti-aging drug today" eight years later | Q36260537 | ||
| Koschei the immortal and anti-aging drugs | Q36292001 | ||
| Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program). | Q36414149 | ||
| Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance | Q37152784 | ||
| Rapamycin extends life- and health span because it slows aging | Q37228766 | ||
| Rapamycin in preventive (very low) doses | Q42558709 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1030-1031 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Aging | Q2845875 |
| P1476 | title | TOR-inhibitors as gero-suppressors | |
| P478 | volume | 7 |
| Q47110143 | Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells | cites work | P2860 |
Search more.